Coronary Artery Disease
Conditions
Keywords
Percutaneous Coronary Intervention, Cardiac troponin, Antiplatelet therapy
Brief summary
This pilot study aims to identify patients at moderate to high risk for peri-procedural (type 4) myocardial infarction or injury after after undergoing an elective coronary intervention (PCI) as measured by high sensitivity troponin T, who might benefit from more potent antiplatelet therapy.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Stable or unknown coronary artery disease (CAD) * Elective coronary intervention * Minimum age of 18
Exclusion criteria
* Present acute coronary syndrome (ACS) * Age under 18 * Pregnancy * Any additional invasive intervention with potential myocardial injury * Non ACS conditions responsible for elevation of cardiac troponin, such as acute pulmonary artery embolism, myocarditis or tachycardia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postprocedural myocardial infarction (type 4a) or injury | up to 72 hours after procedure |
Countries
Germany